Virtu Financial’s Fidelity Disruptive Medicine ETF FMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$343K Buy
13,956
+5,532
+66% +$144K 0.01% 753
2025
Q4
$228K Buy
+8,424
New +$227K 0.01% 963
2023
Q4
Sell
-22,261
Closed -$493K 1704
2023
Q3
$493K Buy
+22,261
New +$533K 0.05% 354

Other funds holding FMED

Virtu Financial's FMED Position: Q1 2026 in Review

Virtu Financial increased its Fidelity Disruptive Medicine ETF (FMED) stake by 66% in Q1 2026, buying an estimated $144K and bringing the position to 13,956 shares worth $343K. The position accounts for 0.01% of the portfolio, ranked #753.

Virtu Financial first reported a position in FMED in Q3 2023 and has held it in 3 quarters since. The position peaked at $493K in Q3 2023. 11 funds tracked by Wall St. Rank hold FMED as of Q1 2026.

  • Virtu Financial held 13,956 shares of Fidelity Disruptive Medicine ETF worth $343K as of Q1 2026.
  • Virtu Financial bought 5,532 Fidelity Disruptive Medicine ETF shares in Q1 2026, an estimated $144K.
  • Fidelity Disruptive Medicine ETF made up 0.01% of Virtu Financial's portfolio in Q1 2026, its #753 holding.
  • Virtu Financial first reported a position in Fidelity Disruptive Medicine ETF in Q3 2023 and has held it in 3 quarters since.
  • Virtu Financial's Fidelity Disruptive Medicine ETF position peaked at $493K in Q3 2023.
  • 11 funds tracked by Wall St. Rank held Fidelity Disruptive Medicine ETF as of Q1 2026.

Based on Virtu Financial's 13F filing for Q1 2026, filed 14 May 2026.